298 related articles for article (PubMed ID: 24708392)
1. Sumatriptan transdermal system can be correctly assembled and applied during migraine attacks.
Meadows KP; Pierce M; O'Neill C; Foster S; Jennings C
Headache; 2014 May; 54(5):850-60. PubMed ID: 24708392
[TBL] [Abstract][Full Text] [Related]
2. Transdermal sumatriptan for acute treatment of migraineurs with baseline nausea.
Schulman EA
Headache; 2012 Feb; 52(2):204-12. PubMed ID: 22229837
[TBL] [Abstract][Full Text] [Related]
3. Sumatriptan iontophoretic transdermal system for the acute treatment of migraine.
Vikelis M; Mitsikostas DD; Rapoport AM
Pain Manag; 2014 Mar; 4(2):123-8. PubMed ID: 24641436
[TBL] [Abstract][Full Text] [Related]
4. Zelrix: a novel transdermal formulation of sumatriptan.
Pierce M; Marbury T; O'Neill C; Siegel S; Du W; Sebree T
Headache; 2009 Jun; 49(6):817-25. PubMed ID: 19438727
[TBL] [Abstract][Full Text] [Related]
5. Sumatriptan iontophoretic transdermal system: history, study results, and use in clinical practice.
Pierce M; O'Neill C; Felker E; Sebree T
Headache; 2013 Sep; 53 Suppl 2():34-42. PubMed ID: 24024601
[TBL] [Abstract][Full Text] [Related]
6. Twelve-month tolerability and efficacy study of NP101, the sumatriptan iontophoretic transdermal system.
Smith TR; Goldstein J; Singer R; Pugach N; Silberstein S; Pierce MW
Headache; 2012 Apr; 52(4):612-24. PubMed ID: 22352764
[TBL] [Abstract][Full Text] [Related]
7. Innovative delivery systems for migraine: the clinical utility of a transdermal patch for the acute treatment of migraine.
Rapoport AM; Freitag F; Pearlman SH
CNS Drugs; 2010 Nov; 24(11):929-40. PubMed ID: 20932065
[TBL] [Abstract][Full Text] [Related]
8. A sumatriptan iontophoretic transdermal system for the acute treatment of migraine.
Goldstein J; Smith TR; Pugach N; Griesser J; Sebree T; Pierce M
Headache; 2012 Oct; 52(9):1402-10. PubMed ID: 22694484
[TBL] [Abstract][Full Text] [Related]
9. Sumatriptan iontophoretic transdermal system: a review of its use in patients with acute migraine.
Garnock-Jones KP
Drugs; 2013 Sep; 73(13):1483-90. PubMed ID: 23912626
[TBL] [Abstract][Full Text] [Related]
10. A Phase I, Open-Label, Single-Dose Safety, Pharmacokinetic, and Tolerability Study of the Sumatriptan Iontophoretic Transdermal System in Adolescent Migraine Patients.
Gutman D; Hellriegel E; Aycardi E; Bigal ME; Kunta J; Chitra R; Kansagra S; Kidron OS; Knebel H; Linder S; Ma Y; Pierce M; Winner PK; Spiegelstein O
Headache; 2016 Sep; 56(8):1300-9. PubMed ID: 27474357
[TBL] [Abstract][Full Text] [Related]
11. Sumatriptan Iontophoretic Transdermal System Reduces Treatment-Emergent Nausea and Is Effective in Patients With and Without Nausea at Baseline - Results From a Randomized Controlled Trial.
Bigal ME; Lipton RB; Newman LC; Pierce MW; Silberstein SD
Headache; 2015 Sep; 55(8):1124-32. PubMed ID: 26178815
[TBL] [Abstract][Full Text] [Related]
12. Sumatriptan iontophoretic transdermal system: A novel approach to migraine-specific therapy.
Goldstein J
Neurol Clin Pract; 2014 Oct; 4(5):454-457. PubMed ID: 29443222
[TBL] [Abstract][Full Text] [Related]
13. Sumatriptan iontophoretic patch for migraine.
Tepper DE
Headache; 2014 Oct; 54(9):1563-4. PubMed ID: 25324166
[No Abstract] [Full Text] [Related]
14. Needle-free subcutaneous sumatriptan for triptan users requiring a change in migraine therapy: efficacy and impact on patient-rated functionality, satisfaction, and confidence.
Rothrock JF; Cady RK; Aurora SK; Brandes JL; Myers JA; Fox AW; Farr SJ
Curr Med Res Opin; 2011 Nov; 27(11):2185-91. PubMed ID: 21942531
[TBL] [Abstract][Full Text] [Related]
15. An open-label trial of a sumatriptan auto-injector for migraine in patients currently treated with subcutaneous sumatriptan.
Landy SH; Tepper SJ; Wein T; Schweizer E; Ramos E
Headache; 2013 Jan; 53(1):118-125. PubMed ID: 23148799
[TBL] [Abstract][Full Text] [Related]
16. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
[TBL] [Abstract][Full Text] [Related]
17. Satisfaction with and confidence in needle-free subcutaneous sumatriptan in patients currently treated with triptans.
Cady RK; Aurora SK; Brandes JL; Rothrock JF; Myers JA; Fox AW; Farr SJ
Headache; 2011 Sep; 51(8):1202-11. PubMed ID: 21812775
[TBL] [Abstract][Full Text] [Related]
18. A sumatriptan patch (Zecuity) for migraine.
Med Lett Drugs Ther; 2015 Nov; 57(1481):151-2. PubMed ID: 26529132
[No Abstract] [Full Text] [Related]
19. Sumatriptan-naproxen migraine efficacy in allodynic patients: early intervention.
Landy S; Hoagland R; Hoagland NA
Headache; 2012 Jan; 52(1):133-9. PubMed ID: 21883200
[TBL] [Abstract][Full Text] [Related]
20. Promethazine plus sumatriptan in the treatment of migraine: a randomized clinical trial.
Asadollahi S; Heidari K; Vafaee R; Forouzanfar MM; Amini A; Shahrami A
Headache; 2014 Jan; 54(1):94-108. PubMed ID: 24182419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
